Home Procurement NewsBausch + Lomb to buy Novartis dry-eye drug for $1.75 billion

Bausch + Lomb to buy Novartis dry-eye drug for $1.75 billion

June 30, 2023•

Bausch + Lomb will purchase a dry-eye drug from Swiss pharma company Novartis for $1.75 billion, the companies said on Friday.

Was this article helpful?

YesNo

Last modified: June 30, 2023

Previous: Analysts are bullish on Nike shares even after the apparel giant’s earnings miss

Next: Dismissed Cadets: Parents Seek Tinubu’s Intervention

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The articles and content featured on this platform are sourced from various contributors and do not necessarily reflect the views or positions of Accountability Lab Nigeria. We do not author or edit the published materials. If you have concerns about any content or would like to request its removal, please contact us at @Accountability Lab Nigeria.

Recent Posts

Recent Comments

No comments to show.

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships

Accountability Lab Nigeria

Copyright © 2021 - Accountability Lab Nigeria

↑

Close